A Prescription For Healthcare Investing

Funding new drug development is challenging. Trials are expensive, complex, and lengthy, and only a fraction of the therapeutics that go into clinical trials will ever come out the other side approved. Sarah Shores welcomes Dr. Andrew Lo, economist, professor at MIT and co-founder of QLS Advisors, a Quantitative Life Sciences Company working to accelerate the pace of change in biomedicine.

Om Podcasten

The Bid breaks down what’s happening in the world of investing and explores the forces changing the economy and finance. From stock market outlooks and megatrends to geopolitics and technology, BlackRock speaks to thought leaders and industry experts from around the globe about the biggest trends moving markets.